Science Explorer Back to mapMap
Discussion
Institution · Edison Pharmaceuticals (United States)

Most cited papers from Edison Pharmaceuticals (United States)

Edison Pharmaceuticals (United States)

What are the most cited papers from Edison Pharmaceuticals (United States)?

The most cited paper from Edison Pharmaceuticals (United States) is "Physical and chemical stability of drug nanoparticles" (Libo Wu, Jian Zhang, Wiwik Watanabe, 2011), with 990 citations. Next come "Circuit Breaker" (734) and "Effect of ACAT Inhibition on the Progression of Coronary Atherosclerosis" (397).

Showing 50 of 61 papers. Every paper with more than 21 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Physical and chemical stability of drug nanoparticles Libo Wu, Jian Zhang, Wiwik Watanabe · Advanced Drug Delivery Reviews Review 11 Feb 2011 990
2 Circuit Breaker Prashant N. Bansal · International Journal of Innovative Science and Research Technology (IJISRT) Open access 13 Aug 2024 734
3 Effect of ACAT Inhibition on the Progression of Coronary Atherosclerosis Steven E. Nissen, Emin Murat Tuzcu, H. Bryan Brewer et al. · New England Journal of Medicine 22 Mar 2006 397
4 PEG-uricase in the management of treatment-resistant gout and hyperuricemia Merry Rubin Sherman, Mark G.P. Saifer, Fernando Pérez-Ruiz · Advanced Drug Delivery Reviews Review 15 Aug 2007 292
5 The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin M.S. Kim, C. J. Small, Sarah A. Stanley et al. · Journal of Clinical Investigation Open access Apr 2000 260
6 Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts Andiliy G. Lai et al. · Journal of Medicinal Chemistry Open access 16 Apr 2015 251
7 Characterization of the Neuroanatomical Distribution of Agouti-Related Protein Immunoreactivity in the Rhesus Monkey and the Rat* Carrie Haskell‐Luevano, Peilin Chen, Chien Li et al. · Endocrinology Mar 1999 230
8 Characterization of a rabbit model of staphylococcal osteomyelitis Mark S. Smeltzer, J. R. Thomas, Sandra G. Hickraon et al. · Journal of Orthopaedic Research® May 1997 216
9 Formation, characterization, and fate of inhaled drug nanoparticles Jian Zhang, Libo Wu, Hak‐Kim Chan et al. · Advanced Drug Delivery Reviews Review 30 Nov 2010 208
10 Initial experience in the treatment of inherited mitochondrial disease with EPI-743 Gregory M. Enns, Stephen L. Kinsman, Susan Perlman et al. · Molecular Genetics and Metabolism Open access 27 Oct 2011 200
11 EPI-743 reverses the progression of the pediatric mitochondrial disease—Genetically defined Leigh Syndrome Diego Martinelli, Michela Catteruccia, Fiorella Piemonte et al. · Molecular Genetics and Metabolism 10 Sep 2012 191
12 Role of the Methoxy Group in Immune Responses to mPEG-Protein Conjugates Merry Rubin Sherman, L. David Williams, Monika A. Sobczyk et al. · Bioconjugate Chemistry Open access 15 Feb 2012 184
13 Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells Mourad Ferdaoussi et al. · Journal of Clinical Investigation Open access 20 Sep 2015 177
14 A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study Simon Tremblay, Vincenza Nigro, Joanne Weinberg et al. · American Journal of Transplantation Open access 24 Jun 2016 172
15 The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer James D. Joseph et al. · eLife Open access 13 Jul 2016 120
16 Switching ST udy of Kidney TRansplant PA tients with Tremor to LCP ‐TacrO ( STRATO ): an open‐label, multicenter, prospective phase 3b study Anthony J. Langone, Steven M. Steinberg, Roberto Gedaly et al. · Clinical Transplantation Open access 26 Jun 2015 120
17 MAP0004, Orally Inhaled DHE: A Randomized, Controlled Study in the Acute Treatment of Migraine Sheena K. Aurora, Stephen David Silberstein, Shashidhar H. Kori et al. · Headache The Journal of Head and Face Pain Apr 2011 110
18 Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins Mark G.P. Saifer, L. David Williams, Monika A. Sobczyk et al. · Molecular Immunology Open access 5 Nov 2013 109
19 Intravenous busulfan in adults prior to haematopoietic stem cell transplantation: a population pharmacokinetic study Laurent Nguyen, F. Léger, Shari S. Lennon et al. · Cancer Chemotherapy and Pharmacology 24 Aug 2005 105
20 Gamma-Tocopherol and Docosahexaenoic Acid Decrease Inflammation in Dialysis Patients Jonathan Himmelfarb, Stephen D. Phinney, Talat Alp Ikizler et al. · Journal of Renal Nutrition 23 Aug 2007 105
21 Challenges for defining minimal clinically important difference (MCID) after spinal cord injury Xiaoliang Wu et al. · Spinal Cord 16 Dec 2014 100
22 α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging William D. Shrader, Akiko Amagata, Adam J. Barnes et al. · Bioorganic & Medicinal Chemistry Letters 25 Apr 2011 97
23 Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients Jennifer Trofe‐Clark, Daniel C. Brennan, Patricia M. West‐Thielke et al. · American Journal of Kidney Diseases Open access 21 Nov 2017 93
24 A0001 in Friedreich ataxia: Biochemical characterization and effects in a clinical trial David R. Lynch, Steven Matthew Willi, Robert B. Wilson et al. · Movement Disorders 28 Jun 2012 90
25 Diabetes Insipidus in Uricase-Deficient Mice: A Model for Evaluating Therapy with Poly(Ethylene Glycol)-Modified Uricase Susan J. Kelly, Marielle Delnomdedieu, Michael I. Oliverio et al. · Journal of the American Society of Nephrology May 2001 80
26 Gender-Biased Activity of the Novel Prolactin Releasing Peptides: Comparison with Thyrotropin Releasing Hormone Reveals Only Pharmacologic Effects Willis K. Samson, Zachary T. Resch, Tonya C. Murphy et al. · Endocrine 1998 80
27 Ictal lack of binding to brain parenchyma suggests integrity of the blood–brain barrier for11C-dihydroergotamine during glyceryl trinitrate-induced migraine Christoph Josef Schankin, Farooq Maniyar, Youngho Seo et al. · Brain Open access 27 May 2016 78
28 Maximizing ER-α Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927 Mehmet Kahraman et al. · ACS Medicinal Chemistry Letters Open access 6 Dec 2018 77
29 Safety and Pharmacokinetics of Dihydroergotamine Mesylate Administered Via a Novel (Tempo™) Inhaler Stephen B. Shrewsbury, Robert O. Cook, Glyn Taylor et al. · Headache The Journal of Head and Face Pain 28 Dec 2007 76
30 Glutathione: A redox signature in monitoring EPI-743 therapy in children with mitochondrial encephalomyopathies Anna Pastore, Sara Petrillo, Giulia Tozzi et al. · Molecular Genetics and Metabolism 24 Mar 2013 61
31 Metabolomic study of carotid–femoral pulse-wave velocity in women Cristina Menni, Massimo Mangino, Marina Cecelja et al. · Journal of Hypertension Open access 9 Dec 2014 59
32 A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models Joseph Kuo, Michael D. Bobardt, Udayan Chatterji et al. · Journal of Pharmacology and Experimental Therapeutics Open access 12 Aug 2019 53
33 Intra-articular orgotein in osteoarthritis of the knee: A placebo-controlled efficacy, safety, and dosage comparison Harris H. McIlwain, Joel C. Silverfield, Don E. Cheatum et al. · The American Journal of Medicine Sep 1989 53
34 Dihydroergotamine: A Review of Formulation Approaches For the Acute Treatment of Migraine Stephen David Silberstein, Shashidhar H. Kori · CNS Drugs 26 Apr 2013 49
35 Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Nebulized Sodium Nitrite (AIR001) Following Repeat-Dose Inhalation in Healthy Subjects Peter J. Rix, Andrew Vick, Neil Attkins et al. · Clinical Pharmacokinetics Open access 25 Nov 2014 48
36 Itraconazole nanosuspension for oral delivery: Formulation, characterization and in vitro comparison with marketed formulation. Mahendra Nakarani, Ambikanandan R. Misra, Jayvadan K. Patel et al. · PubMed Open access 2010 47
37 Optimization of an indazole series of selective estrogen receptor degraders: Tumor regression in a tamoxifen-resistant breast cancer xenograft Steven P. Govek, Johnny Y. Nagasawa, Karensa L. Douglas et al. · Bioorganic & Medicinal Chemistry Letters 10 Oct 2015 46
38 Mapping the Design Process for Urban Ecology Researchers Alexander J. Felson, Mitchell A. Pavao‐Zuckerman, Timothy R. Carter et al. · BioScience Nov 2013 45
39 Improved Hydrodynamics for USP Apparatus 2 A H Beckett, Tinh T. Quach, Glenn S. Kurs · Dissolution Technologies Open access 1996 44
40 Erythropoietin-Coated ZP-Microneedle Transdermal System: Preclinical Formulation, Stability, and Delivery Elaine E. Peters, Mahmoud Ameri, Xiaomei Wang et al. · Pharmaceutical Research 18 Jan 2012 44
41 Radiographic progression by Prostate Cancer Working Group ( PCWG )‐2 criteria as an intermediate endpoint for drug development in metastatic castration‐resistant prostate cancer Guru Sonpavde, Gregory R. Pond, Andrew J. Armstrong et al. · British Journal of Urology Open access 3 Dec 2013 44
42 The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic mice Philippe A. Gallay, Daren Ure, Michael D. Bobardt et al. · PLoS ONE Open access 10 Jun 2019 42
43 Identification of an Orally Bioavailable Chromene-Based Selective Estrogen Receptor Degrader (SERD) That Demonstrates Robust Activity in a Model of Tamoxifen-Resistant Breast Cancer Johnny Y. Nagasawa et al. · Journal of Medicinal Chemistry Open access 7 Aug 2018 41
44 The effect of hydrogen bonds on the dynamic mechanical properties of glassy polymethacrylates from 77[ddot]K Mitchel C. Shen, Jack D. Strong, Frank J. Matusik · Journal of Macromolecular Science Part B Mar 1967 40
45 New Pacidamycins Produced by Streptomyces coeruleorubidus, NRRL 18370. Richard Fronko, Jean C. Lee, J. G. Galazzo et al. · The Journal of Antibiotics Open access 2000 38
46 Brain uptake of Tc99m-HMPAO correlates with clinical response to the novel redox modulating agent EPI-743 in patients with mitochondrial disease Francis G. Blankenberg, Stephen L. Kinsman, Bruce H. Cohen et al. · Molecular Genetics and Metabolism 28 Sep 2012 36
47 Cocaine- and Amphetamine-Regulated Transcript Peptide in the Rat Epididymis: An Immunohistochemical and Electrophysiological Study1 Nae J. Dun, S.L. Dun, P.Y.D. Wong et al. · Biology of Reproduction Open access Nov 2000 33
48 Preparation of Long-Acting Superoxide Dismutase Using High Molecular Weight Polyethylene Glycol (41,000-72,000 Daltons) Ralph Somack, Mark G.P. Saifer, L. David Williams · Free Radical Research Communications 1991 31
49 Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma Stephen B. Shrewsbury, AP Bosco, Paul S. Uster · International Journal of Pharmaceutics 23 Aug 2008 29
50 Rencofilstat, a cyclophilin inhibitor: A phase 2a, multicenter, single‐blind, placebo‐controlled study in F2/F3 NASH Stephen A. Harrison, Patrick Mayo, Todd M. Hobbs et al. · Hepatology Communications Open access 22 Oct 2022 28

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.